Inventor · disambiguated record
Hirohito Katayama
Also filed as: KATAYAMA HIROHITO
12 granted patents·435 citations·filing 1988–1992
94Inventor score
Files withFUJISAWA PHARMACEUTICAL CO12
Top patents by PatentIndex Score
12 records- 0194US5155114AMethod of treatment using pyrazolopyridine compoundFUJISAWA PHARMACEUTICAL CO·Filed 1991·Granted Oct 13, 1992·61 cites·1 claims
- 0292US5296490APharmaceutically useful pyrazolopyridinesFUJISAWA PHARMACEUTICAL CO·Filed 1992·Granted Mar 22, 1994·65 cites·6 claims
- 0392US4925849APharmaceutically useful pyrazolopyridinesFUJISAWA PHARMACEUTICAL CO·Filed 1988·Granted May 15, 1990·45 cites·9 claims
- 0489US4985444APyrazolopyridine compound and processes for preparation thereofFUJISAWA PHARMACEUTICAL CO·Filed 1990·Granted Jan 15, 1991·72 cites·16 claims
- 0582US5234930APyrazolopyridine compounds which have useful pharmaceutical utilityFUJISAWA PHARMACEUTICAL CO·Filed 1992·Granted Aug 10, 1993·43 cites·11 claims
- 0682US5204346APyrazolopyridine compoundsFUJISAWA PHARMACEUTICAL CO·Filed 1991·Granted Apr 20, 1993·46 cites·5 claims
- 0782US4994453APyrazolopyridine compound and processes for preparation thereofFUJISAWA PHARMACEUTICAL CO·Filed 1989·Granted Feb 19, 1991·19 cites·1 claims
- 0876US5102869AMethod of treating kidney disease using pyrazolopyridine compoundFUJISAWA PHARMACEUTICAL CO·Filed 1990·Granted Apr 7, 1992·21 cites·1 claims
- 0968US5179103APharmaceutically useful pyrazolopyridinesFUJISAWA PHARMACEUTICAL CO·Filed 1991·Granted Jan 12, 1993·10 cites·7 claims
- 1068US5102878APharmaceutical method of treatment using pyrazolopyridine compoundFUJISAWA PHARMACEUTICAL CO·Filed 1990·Granted Apr 7, 1992·14 cites·1 claims
- 1163US5338743ANew use of the adenosine antagonistFUJISAWA PHARMACEUTICAL CO·Filed 1992·Granted Aug 16, 1994·29 cites·15 claims
- 1260US5087629APharmacologically active pyrazolopyridine compoundsFUJISAWA PHARMACEUTICAL CO·Filed 1990·Granted Feb 11, 1992·10 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Hirohito Katayama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →